Form 4: MAIA Biotechnology Director Ramiro Guerrero Reports Acquisition of Stock Options

Director Ramiro Guerrero reports acquiring 10,225 stock options in MAIA Biotechnology, Inc. on December 31, 2024.

Summary

• Ramiro Guerrero, a director of MAIA Biotechnology, Inc., filed a Form 4 on January 3, 2025, reporting a transaction.
• On December 31, 2024, Guerrero acquired 10,225 stock options with an exercise price of $1.98.
• These options, granted under the company's 2021 Equity Incentive Plan, vest immediately and are exercisable from the grant date.
• Following the transaction, Guerrero directly owns 10,225 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• Immediate vesting of the options could incentivize the director to contribute to the company's success promptly.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The acquisition of stock options by a director can align their interests with shareholders, potentially leading to increased focus on long-term value creation.

Key Dates